Achieving Comprehensive Diabetes Management: The Role of Combination Therapy

This event is an CPD-accredited hybrid educational event designed to deepen healthcare professionals’ understanding of contemporary, evidence-based approaches to the management of Type 2 Diabetes Mellitus.

The programme focuses on the progressive nature of Type 2 diabetes and the clinical rationale for timely combination therapy, particularly the role of combining metformin with DPP-4 inhibitors (Dipeptidyl Peptidase-4 inhibitors) in achieving durable glycaemic control while minimizing adverse effects such as hypoglycaemia and weight gain.

Delivered by highly qualified, experienced resource persons, this interactive session blends scientific evidence, guideline-based recommendations, and practical clinical insights. Participants will benefit from live discussions, question-and-answer sessions, and real-world perspectives relevant to both hospital and ambulatory care settings.

The event will be hosted in person at UniChem HQ (Uniworld Conference Room) and streamed live for virtual participants, ensuring broad access and engagement.

WHY YOU SHOULD ATTEND

i. To strengthen your understanding of Type 2 diabetes as a progressive disease

ii. To explore when and why combination therapy becomes necessary

iii. To gain practical insight into the role of metformin + DPP-4 inhibitor combinations

iv. To engage directly with expert faculty through interactive Q&A sessions

v. To earn CPD points accredited by the Medical and Dental Council (MDC)

vii. To stay current with evolving best practices in diabetes management

This is a clinically relevant session designed to support better decision-making and improved patient outcomes.

EVENT HIGHLIGHTS

1. CPD-accredited hybrid training (in-person and virtual)

2. Expert-led keynote presentation on comprehensive diabetes management

3. Practical discussion on combination therapy strategies

4. Live Q&A sessions for both online and in-person participants

5. Recorded session available post-event via the CES platform

6. Certificate Awarded upon successful completion

7. Seamless CPD point crediting through MDC

SUMMARY OF TOPICS TO BE COVERED

1. Fundamentals of Type 2 diabetes management

2. The progressive pathophysiology of Type 2 diabetes

3. Limitations of long-term monotherapy

4. Clinical rationale for combination therapy

5. Role of metformin + DPP-4 inhibitor combinations in glycaemic control

6. Safety considerations, including hypoglycaemia and weight effects

7. Translating evidence and guidelines into everyday clinical practice

PARTICIPANT CONSENT AND DATA PRIVACY NOTICE

By registering for “Achieving Comprehensive Diabetes Management: The Role of Combination Therapy”, you consent to participate in this CPD training hosted by Continuous Education Services (CES) on behalf of UniChem Ghana Ltd and Luex Ghana Ltd.

Your registration information will be used solely to facilitate the event and to issue CPD points through the Medical and Dental Council (MDC). CES is fully committed to safeguarding your personal data and will not share your information with any third party other than the MDC, and strictly for the purpose of CPD accreditation.

Participation is entirely voluntary. You may opt out of the session at any time without the need for further action. All participant information will be treated with the highest level of confidentiality and in line with applicable data protection standards.

PROUDLY ORGANIZED AND SPONSORED BY

The in-person component of the event will take place at UniChem HQ (Uniworld Conference Room)